Milestone Pharmaceuticals Inc (MIST) reports a successful product launch and strategic trials, despite facing early-stage revenue hurdles and increased expenses.

Louisiana Department of Insurance, orders PBMs and insurers in the state to bring their reimbursement formulas in line with a ...

The company initiated its next development program for etripamil, starting a Phase III AFib-RVR trial. “We have initiated our Phase III trial for atrial fibrillation with rapid ventricular rate or ...

Detailed price information for Milestone Pharmaceuticals Inc (MIST-Q) from The Globe and Mail including charting and trades.

A Baton Rouge judge allowed Louisiana Insurance Commissioner Tim Temple’s pharmacy reimbursement directive to take effect, ...

If you've been relying on Express Scripts for your 90-day refills and home delivery, 2026 brings a critical shift: a new 'Copay Assurance' program that caps out-of-pocket costs, paired with stricter ...

Running two drugstores is a break-even endeavor for Primary Care Pharmacy Services owner Anthony Bertola, as long as he ...

From the column: "While the hospital and pharmacy pay a discounted 340B price for a prescription medication, the patient ...

Independent pharmacies fear closure as profit margins grow slim for high-cost prescription drugs, while members of the South ...

Express Scripts, part of Cigna’s Evernorth, is overhauling its pharmacy benefits model to lower out-of-pocket costs and boost ...

The insurer plans to say goodbye to the ACA exchanges after this year, and is exploring a potential sale of its controversial ...